Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Laminins are the Adhesive Proteins of Basal Lamina00:55

Laminins are the Adhesive Proteins of Basal Lamina

2.2K
Laminins are heterotrimeric proteins with high molecular mass found in the extracellular matrix. Each laminin molecule is composed of three chains, viz. alpha, beta, and gamma, coded by five, four, and three paralogous genes, respectively. Laminins are categories based on the compositions of the three chains.
In humans, the five forms of alpha chains are LAMA 1, LAMA 2, LAMA 3, LAMA 4, and LAMA 5. The four forms of beta chains are LAMB 1, LAMB 2, LAMB 3, and LAMB 4. The three forms of gamma...
2.2K
Type IV Collagen of Basal Lamina01:05

Type IV Collagen of Basal Lamina

2.3K
Type IV collagen is a 400 nm long, network-forming collagen that acts as a barrier between the epithelial and endothelial cells. Type IV collagen  forms the backbone of the basement membrane by scaffolding with laminin, entactin, proteoglycans, and fibronectin. Apart from rendering structural support to the basement membrane, it also helps entail signaling potentials necessary for both pathological and physiological functions.
A type IV collagen molecule has six alpha chains which can...
2.3K
Basal Lamina are the Specialized Form of ECM01:03

Basal Lamina are the Specialized Form of ECM

2.8K
The basal lamina is a thin extracellular layer that lies underneath the cells and separates them from other tissues. The three layers of the basal lamina are lamina lucida, lamina densa and lamina reticularis. The basal lamina, a mixture of glycoproteins and collagen, provides an attachment site for the epithelium, separating it from underlying connective tissue. The framework of basal lamina has other essential proteins such as laminins mesh, perlecan, entactin, and type IV collagen.
Proteins...
2.8K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

The relationship between intracranial artery hemodynamics and subjective cognitive decline in patients with cerebral small vessel disease: a 4D flow study.

Frontiers in neuroscience·2026
Same author

Differential immune responses to SFTSV Gn and Gc mRNA vaccines in mice and dogs.

Microbiology spectrum·2026
Same author

Multimodal MRI-based quantification of tumoral spatial heterogeneity for preoperative upgrade prediction of ductal carcinoma in situ.

Scientific reports·2026
Same author

Selenium-induced metabolic reprogramming in soybean activates nucleotide transport pathways and suppresses primary carbon metabolism.

Scientific reports·2026
Same author

A Rare Case of Anti-Integrin β4 IgG-Positive Bullous Pemphigoid Lacking Mucosal Lesions.

The Journal of dermatology·2026
Same author

Refractory high-risk mucous membrane pemphigoid treated with Telitacicept.

The British journal of dermatology·2026

Related Experiment Video

Updated: Aug 23, 2025

Granulocyte-dependent Autoantibody-induced Skin Blistering
12:23

Granulocyte-dependent Autoantibody-induced Skin Blistering

Published on: October 12, 2012

10.6K

Anti-Laminin 332-Type Mucous Membrane Pemphigoid.

Luhuai Shi1, Xiaoguang Li2, Hua Qian2

  • 1Dermatology Hospital of Jiangxi Province, Jiangxi Provincial Clinical Research Center for Skin Diseases, Candidate Branch of National Clinical Research Center for Skin Diseases, Dermatology Institute of Jiangxi Province, The Affiliated Dermatology Hospital of Nanchang University, Nanchang 330001, China.

Biomolecules
|October 27, 2022
PubMed
Summary

Anti-laminin 332-type mucous membrane pemphigoid (MMP) is a rare autoimmune disease diagnosed by detecting anti-LM332 autoantibodies. Current treatments are limited, and a potential link to tumors requires further investigation.

Keywords:
cicatricial pemphigoiddiagnosislaminin 332mucous membrane pemphigoidtreatmenttumor

More Related Videos

Recognition of Epidermal Transglutaminase by IgA and Tissue Transglutaminase 2 Antibodies in a Rare Case of Rhesus Dermatitis
10:27

Recognition of Epidermal Transglutaminase by IgA and Tissue Transglutaminase 2 Antibodies in a Rare Case of Rhesus Dermatitis

Published on: December 15, 2011

24.6K
Detection of Nuclear Blebbing and DNA Leakage in Mammalian Cells by Immunofluorescence
06:23

Detection of Nuclear Blebbing and DNA Leakage in Mammalian Cells by Immunofluorescence

Published on: January 17, 2025

856

Related Experiment Videos

Last Updated: Aug 23, 2025

Granulocyte-dependent Autoantibody-induced Skin Blistering
12:23

Granulocyte-dependent Autoantibody-induced Skin Blistering

Published on: October 12, 2012

10.6K
Recognition of Epidermal Transglutaminase by IgA and Tissue Transglutaminase 2 Antibodies in a Rare Case of Rhesus Dermatitis
10:27

Recognition of Epidermal Transglutaminase by IgA and Tissue Transglutaminase 2 Antibodies in a Rare Case of Rhesus Dermatitis

Published on: December 15, 2011

24.6K
Detection of Nuclear Blebbing and DNA Leakage in Mammalian Cells by Immunofluorescence
06:23

Detection of Nuclear Blebbing and DNA Leakage in Mammalian Cells by Immunofluorescence

Published on: January 17, 2025

856

Area of Science:

  • Immunodermatology
  • Autoimmune Bullous Diseases
  • Oncology

Background:

  • Anti-laminin (LM) 332-type mucous membrane pemphigoid (MMP) is a rare autoimmune bullous disorder.
  • Distinct from other MMP types solely by detecting circulating anti-LM332 autoantibodies.
  • Originally identified as anti-epiligrin cicatricial pemphigoid.

Purpose of the Study:

  • To review the current diagnostic and therapeutic strategies for anti-LM332-type MMP.
  • To explore the potential association between anti-LM332-type MMP and various tumors.
  • To highlight the challenges in clinical diagnosis and treatment standardization.

Main Methods:

  • Review of existing immunological methods for anti-LM332 autoantibody detection.
  • Analysis of current treatment protocols and their efficacy.
  • Examination of evidence linking anti-LM332-type MMP with malignancy.

Main Results:

  • Various immunological detection methods exist, but none are universally adopted for clinical diagnosis.
  • Standardized treatment is lacking, and complete cures are difficult to achieve.
  • Growing evidence suggests a significant correlation between anti-LM332-type MMP and cancer.

Conclusions:

  • Accurate diagnosis and effective treatment for anti-LM332-type MMP remain challenging.
  • The association with tumors warrants further research and clinical attention.
  • A unified approach to diagnosis and treatment is needed for this rare condition.